Onaiza Cadoret-Manier

Onaiza joined the Ardelyx board of directors in March 2020. From March 2022 to March 2024, Onaiza served as chief global product strategy and operations officer at Ionis Pharmaceuticals, and previously held the role of Chief Corporate Development and Commercial Officer. Prior to that, she was the chief commercial officer for Grail Biosciences, an early detection genomics company., as well as vice president of the respiratory Franchise at Genentech. Onaiza also has held multiple senior management positions overseeing corporate strategy, alliances, and marketing and sales for numerous disease areas for Genentech, Pfizer and Amylin Pharmaceuticals.

Onaiza also serves on the board of directors of Ventyx Biosciences.

She has an M.B.A. from the University of Chicago and a bachelor’s degree in economics and accounting from City University of New York Queens College.